GlassScriptPhysician profile
Constance M Crane
NPI 1205436300
$1,732.93
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $168 · 2022: $584 · 2023: $582 · 2024: $399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $981.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $980.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $394.03 | 2021-2024 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $255.25 | 2021-2024 | Breztri, Farxiga, Airsupra |
| Abbvie INC. | $251.87 | 2021-2023 | |
| Lilly USA, LLC | $150.32 | 2022-2024 | Mounjaro |
| Glaxosmithkline, LLC. | $91.30 | 2022-2023 | Trelegy Ellipta |
| Amgen INC. | $68.51 | 2021-2024 | Repatha, Otezla |
| Dexcom, INC. | $61.50 | 2023-2024 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $57.92 | 2021-2023 | Jardiance |
| Shield Therapeutics INC | $56.71 | 2023-2024 | Accrufer |
| Alkermes, INC. | $55.32 | 2021-2023 | Vivitrol |
| Lundbeck LLC | $41.78 | 2023 | Rexulti |
| Genentech USA, INC. | $39.76 | 2021-2022 | |
| Pfizer INC. | $39.51 | 2023-2024 | |
| Exact Sciences Corporation | $38.04 | 2024 | Cologuard Collection Kit |
| Phathom Pharmaceuticals, INC. | $26.85 | 2024 | Voquezna |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $22.62 | 2022 | |
| Gilead Sciences, INC. | $22.12 | 2023 | |
| Hologic Sales and Service, LLC | $21.16 | 2024 | Aptima |
| Amarin Pharma, INC. | $14.32 | 2022 | |
| Philips North America LLC | $12.24 | 2022 | |
| Eisai INC. | $11.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Constance Crane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.